These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8097096)

  • 1. Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS.
    Nelson MR; Erskine D; Hawkins DA; Gazzard BG
    AIDS; 1993 Mar; 7(3):375-8. PubMed ID: 8097096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
    J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.
    Pertel P; Hirschtick R; Phair J; Chmiel J; Poggensee L; Murphy R
    J Acquir Immune Defic Syndr (1988); 1992; 5(11):1069-74. PubMed ID: 1357151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
    Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
    AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Digestive cytomegalovirus disease in AIDS patients].
    Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
    Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
    Hoover DR; Peng Y; Saah A; Semba R; Detels RR; Rinaldo CR; Phair JP
    Arch Ophthalmol; 1996 Jul; 114(7):821-7. PubMed ID: 8660165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus disease in AIDS: the Edinburgh experience.
    Cheong I; Flegg PJ; Brettle RP; Welsby PD; Burns SM; Dhillon B; Leen CL; Gray JA
    Int J STD AIDS; 1992; 3(5):324-8. PubMed ID: 1327173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus seroconversion as a cofactor for progression to AIDS.
    Robain M; Boufassa F; Hubert JB; Persoz A; Burgard M; Meyer L;
    AIDS; 2001 Jan; 15(2):251-6. PubMed ID: 11216935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients.
    Mentec H; Leport C; Leport J; Marche C; Harzic M; Vildé JL
    AIDS; 1994 Apr; 8(4):461-7. PubMed ID: 8011249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).
    Saillour F; Bernard N; Ragnaud JM; Morlat P; Blanchard Y; Monlun E; Labouyrie E; Chene G; Dabis F
    J Infect; 1997 Sep; 35(2):155-61. PubMed ID: 9354350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
    AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
    Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
    Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
    PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.